|
FY2025
12 months to Jan 3, 2026
|
FY2024
12 months to Dec 28, 2024
|
FY2023
12 months to Dec 30, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Jan 1, 2022
|
|
|---|---|---|---|---|---|
| Net Cash Flows From (To) Operating Activities: | |||||
| Net income | |||||
| Non-cash items included in net income: | |||||
| Depreciation and amortization | |||||
| Other post-retirement and post-employment benefits | |||||
| Stock-based compensation | |||||
| Deferred income taxes | |||||
| Asset impairment charges | |||||
| Loss on sale of subsidiary | |||||
| Other – net | |||||
| Net increase (decrease) in cash from operating assets and liabilities | |||||
| Decrease in other liabilities | |||||
| Net cash flows from (to) operating activities | |||||
| Net Cash Flows From (To) Investing Activities: | |||||
| Capital expenditures | |||||
| Acquisition spending, net of cash acquired | |||||
| Capitalized software | |||||
| Purchase of investments | |||||
| Sales or maturities of investments | |||||
| Net proceeds from sale of subsidiary | |||||
| Other – net | |||||
| Net cash flows from (to) investing activities | |||||
| Net Cash Flows From (To) Financing Activities: | |||||
| Payments of debt | |||||
| Proceeds from debt | |||||
| Dividends paid | |||||
| Purchase of HNI Corporation common stock | |||||
| Proceeds from sales of HNI Corporation common stock | |||||
| Debt-issuance costs | |||||
| Withholding related to net share settlements of equity based awards | |||||
| Proceeds from COLI | |||||
| Other – net | |||||
| Net cash flows from (to) financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | |||||
| Cash, cash equivalents, and restricted cash at end of period | |||||
Loading...